A pilot study using nabilone for symptomatic treatment in Huntington's disease

2009 ◽  
Vol 24 (15) ◽  
pp. 2254-2259 ◽  
Author(s):  
Adrienne Curtis ◽  
Ian Mitchell ◽  
Smitaa Patel ◽  
Natalie Ives ◽  
Hugh Rickards
Keyword(s):  
Pilot Study ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Symptomatic Treatment

Voxel-based morphometry at the single subject level: a pilot study in early Huntington's disease

2008 ◽  
Vol 35 (S 01) ◽  
Author(s):  
M Mühlau ◽  
A Wohlschläger ◽  
C Gaser ◽  
M Valet ◽  
S Nunnemann ◽  
...  
Keyword(s):  
Pilot Study ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Single Subject ◽  
Voxel Based Morphometry

Longitudinal pilot-study of Sustained Attention to Response Task and P300 in manifest and pre-manifest Huntington's disease

2013 ◽  
Vol 9 (1) ◽  
pp. 10-20 ◽  
Author(s):  
Ellen P. Hart ◽  
Eve M. Dumas ◽  
Erik W. van Zwet ◽  
Karin van der Hiele ◽  
Caroline K. Jurgens ◽  
...  
Keyword(s):  
Pilot Study ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Sustained Attention ◽  
Response Task

scholarly journals QEEG Measures in Huntington’s Disease: A Pilot Study

PLoS Currents ◽  
2010 ◽  
Author(s):  
Aimee M. Hunter ◽  
Yvette M. Bordelon ◽  
Ian A. Cook ◽  
Andrew F. Leuchter
Keyword(s):  
Pilot Study ◽  
Huntington's Disease ◽  
Huntington’S Disease

Contemporary Dance Practice Improves Motor Function and Body Representation in Huntington’s Disease: A Pilot Study

2019 ◽  
Vol 8 (1) ◽  
pp. 97-110 ◽  
Author(s):  
Iris Trinkler ◽  
Philippe Chéhère ◽  
Julie Salgues ◽  
Marie-Lorraine Monin ◽  
Sophie Tezenas du Montcel ◽  
...  
Keyword(s):  
Pilot Study ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Motor Function ◽  
Body Representation ◽  
Contemporary Dance

scholarly journals Euthanasia and physician-assisted suicide in Huntington's disease in The Netherlands

2012 ◽  
Vol 25 (2) ◽  
pp. 339-340 ◽  
Author(s):  
Suzanne J. Booij ◽  
Dick P. Engberts ◽  
Aad Tibben ◽  
Raymund A. C. Roos
Keyword(s):  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Assisted Suicide ◽  
Autosomal Dominant ◽  
Psychiatric Symptoms ◽  
Age Of Onset ◽  
Symptomatic Treatment ◽  
Physician Assisted Suicide ◽  
Dna Testing ◽  
Duration Of Illness

Huntington's disease (HD) is a progressive autosomal dominant neurodegenerative disease characterized by chorea, hypokinesia, psychiatric symptoms, and dementia. The age of onset is usually between 30 and 50 years; the duration of illness is from 10–20 years. The rate of suicide in patients is higher than in the general population and is the second most common cause of death in HD after pneumonia (Bindler et al., 2009). Currently, symptomatic treatment is available, but there is no cure. The identification of HD-gene in 1993 made DNA testing possible in individuals at risk.

The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington's disease: a pilot study

2012 ◽  
Vol 20 (9) ◽  
pp. 1325-1329 ◽  
Author(s):  
J. A. Thompson ◽  
T. M. Cruickshank ◽  
L. E. Penailillo ◽  
J. W. Lee ◽  
R. U. Newton ◽  
...  
Keyword(s):  
Pilot Study ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Multidisciplinary Rehabilitation ◽  
Middle Stage
Sign in / Sign up

Export Citation Format

Share Document